Web Banner for Convention 2020 (2)

October 2-4, 2020


The Arizona Pharmacy Association is pleased to present this 2.5 day annual conference that provides continuing education, recognition, and networking opportunities for pharmacy professionals of all practice settings. We will be offering a full line up of both live and on-demand CPE sessions.

Can't make it? Don't  worry! All sessions will be recorded so even if you can't dial in live you still will be eligible to receive the same number of CPE's. 

Interested in Exhibitor or Sponsorship Opportunities?  CLICK HERE


Schedule of Events


Painfully Aware: A Review of the Evidence of Acute and Chronic Pain
Alaa Abd-Elsayed, MD, MPH

Pharmacists/Technicians learning objectives:

  • Apply evidence-based acute pain management principles in daily practice.
  • Apply pain management treatment and prevention protocols in different patient populations.
  • Describe how pain works and the goals of treating acute pain.

UAN: 0100-0000-20-115-L08-P/T

5:35PM - 6:35PM | BREAKOUT SESSION: An Immunization Update and the Arizona Law
Conchetta Lesser, PharmD, BCACP

Pharmacists/Technicians learning objectives:

  • Review current CDC guidelines for immunizations
  • Identify changes made to guidelines within the last year, including the emergence of focus on shared clinical decision making and how this affects pharmacist recommendations.
  • Define how these changes impact community pharmacists within the Arizona law.

UAN: 0100-0000-20-116-L06-P/T

5:35PM - 6:55PM | Breakout Session:
Antimicrobial Stewardship Dynamics: ONE Health, Transitioning Care, and Tracking Resistance in Arizona
Mark Redell, PharmD; Kimberly Halton Welker, PharmD; Vanthida Huang, PharmD, FCCP.

Pharmacists/Technicians learning objectives: 

  • Recognize the threat of antibiotic resistance on a state, national and global perspective.
  • Describe the momentum of expert groups on antibiotic resistance, such as the international One Health Initiative, United Nations Resolution, and WHO world stage on antibiotic resistance.
  • List opportunities to improve transitions of care in patients receiving antibiotics, including transfers between the hospital, home and long-term care.
  • List the performance measures in the Joint Commission statement for Ambulatory Care (effective Jan 1 2020).
  • Develop a plan to interpret and communicate results from institutional and community antibiograms, and the role of surveillance studies.
  • Define the future of antibiotic development and the current realities in Congress.

UAN: 0100-0000-20-117-L01-P/T

Sponsored by PillPack 

Join us for virtual networking and to recognize the 2020 Pharmacy Appreciation Award Recipients 



Get your body and mind ready for networking and education.
Nancy Costlow, PharmD, BCSCP

8:00AM - 9:30AM | GENERAL SESSION: 2020 Pharmacy Law Update
Roger Morris, RPh,  JD

Pharmacists/Technicians learning objectives:

  • Describe new legislative updates pertaining to the practice of pharmacy in Arizona.
  • Describe the practical ramifications of proposed state and national legislative initiatives.
  • Recognize emerging patterns that will broadly affect the healthcare profession and pharmacy practice.

UAN: 0100-0000-20-118-L03-P/T

9:30AM - 10:00AM | NON-ACCREDITED EDUCATION PROGRAM: Thinking Beyond Glycemia: The Importance of Managing Heart Failure Risks in Type 2 Diabetes
Provided by AstraZeneca

8:00AM - 9:30AM | BREAKOUT SESSION: Transformation by Association
Grace Akoh-Arrey, PharmD, CDE, BCACP, FAzPA;
Rose Colucci, PharmD, BCACP

Objectives: (Pharmacist Only)

  • Describe Project Vision and the role of a Diabetes Care and Education Specialist.
  • Demonstrate the value of Diabetes Care and Education Specialists within your healthcare community.
  • Establish Diabetes Care and Education Specialists as the drivers of change.
    UAN: 0100-9999-20-154-L04-P

10:05AM - 11:05AM | BREAKOUT SESSION: Innovations in Medication Safety: No Parking Between 8-5PM
Kevin Boeson, PharmD

Pharmacist/Technician learning objectives:

  • Explain the morbidity, mortality and costs associated with adverse drug events.
  • Describe the impact of competitive inhibition on medication efficacy and safety.
  • Recognize opportunities to prevent adverse drug events.

UAN: 0100-0000-20-119-L05-P/T

10:05AM - 11:05AM | BREAKOUT SESSION: A Weighty Decision: The Role of Medication for Weight Management in Type 2 Diabetes
Erin Raney, PharmD, BCPS, BC-ADM


  • Explain the impact of overweight and obesity on diabetes care.
  • Describe the effect of oral and injectable anti-diabetic medications on weight.
  • Compare and contrast pharmacologic agents for the treatment of obesity.
  • Identify patients with diabetes who are appropriate candidates for weight loss medications.

UAN: 0100-9999-20-155-L01-P

10:05AM - 11:05AM | BREAKOUT SESSION: Biostats 101: A Quick Review for the Board Exams and Improving Patient Care
Jacob Schwarz, PharmD, BCIDP, BCCCP, BCPS

Pharmacist learning objectives:  (Pharmacist only)

  • Identify different types of data (nominal, ordinal, interval/ration) to determine appropriate measure of central tendency, and appropriate test for statistical significance.
  • Define and evaluate odds ration and risk ratio reported from literature.
  • Interpret statistical significance based on reported odds ratios, risk ratios, or confidence intervals.
  • Define and calculate the absolute risk, relative risk, number needed to treat given data from a study.

UAN: 0100-0000-20-120-L04-P

10:05AM - 11:05AM | BREAKOUT SESSION: Medication Optimization In Older Adults: Use of Shared Decision Making Model
Laura Hanson, PharmD, BCGP

Pharmacist learning objectives:  (Pharmacist only)

  • Describe challenges commonly encountered when designing medication regimens for older adults.
  • Define the shared decision-making model.
  • Compare the use of shared decision-making with other models of care related to medication management.

UAN: 0100-0000-20-121-L04-P

10:05AM - 11:05AM | STUDENT TRACK: Residency Prep Panel: Part 1
Dawn Gerber, PharmD, BCGP, FASCP; Amy Kennedy, PharmD, BCACP, FAPhA

Pharmacist learning objectives:

  • Describe effective methods of preparing for the residency application process.
  • Identify factors of a successful interview.
  • Recognize techniques  for navigating The Match process.

UAN: 0100-0000-20-147-L04-P

11:15AM - 12:15PM | BREAKOUT SESSION: Leadership and Engagement Skills in Pharmacy: An Engaged Team Will Always Outperform One That Is Not. Business Skills for the Pharmacy Professional
Jarrod Gonzales, PharmD 

Pharmacists/Technicians learning objectives:

  • Describe employee engagement.
  • Identify myths of employee engagement.
  • List 7 characteristics of a highly engaged team.
  • Describe 5 communication styles.

UAN: 0100-0000-20-122-L04-P/T

11:15AM - 12:15PM | BREAKOUT SESSION: When Clinic and Home Readings Don’t Agree: Managing White Coat Hypertension and Home Monitoring of Blood Pressure
Beth Zerr, PharmD, BCACP, AE-C

Pharmacists/Technicians learning objectives:

  • Describe the current recommendations for home blood pressure monitoring.
  • Identify the implications of chronotherapy (timing of BP medication administration) and discuss the potential impact on cardiovascular outcomes.
  • Provide education to patients regarding best practices for home BP monitoring, specifically focusing on device selection, timing of readings and timing of medication administration.
  • Recognize the data regarding cardiovascular risks association with White Coat Hypertension.
  • Create a care plan for patients with White Coat Hypertension.

UAN: 0100-0000-20-123-L01-P/T

11:15AM - 12:15PM |BREAKOUT SESSION: Anticoagulation in Nonvalvular Atrial Fibrillation:  Differences for Patients on Dialysis
Maura Jones, PharmD, BCPS; Rim Hadgu, PharmD,

Pharmacist learning objectives:  (Pharmacist only)

  • Identify patients with nonvalvular atrial fibrillation eligible for anticoagulation.
  • Describe anticoagulant drug dosing in patients on dialysis
  • Analyze current literature on safety and efficacy of anticoagulants used in patients with nonvalvular atrial fibrillation undergoing dialysis
  • Develop appropriate anticoagulant recommendation based on evidence and patient specific factors.

UAN: 0100-0000-20-124-L01-P

11:15AM - 12:15PM | BREAKOUT SESSION: Resume Builder 101
Phillip Ieng, PharmD

Pharmacists/Technicians learning objectives:

  • Identify what recruiters are looking for in a resume.
  • Recognize good resumes from bad ones.
  • List important sections featured in a resume.
  • Define what a resume is and how it differs from a CV.

UAN: 0100-0000-20-125-L04-P/T

11:15AM - 12:15PM | BREAKOUT SESSION: LDL: How Low Can You Go?
Lucas Nyabero, PharmD
Objectives: (Pharmacist Only)

  • Recognize potential challenges with lipid panel results, including laboratory interpretation and patient and provider resistance.
  • Describe key features of primary literature regarding safety and efficacy of low LDL.
  • Identify ways to address low LDL results with patients and providers in your clinical practice.

UAN: 0100-9999-20-143-L01-P

12:15PM - 1:00PM | NON-ACCREDITED EDUCATION PROGRAM: BAQSIM ID (glucagon) Nasal Powder Product Theatre
Provided by Lilly, US LLC

1:00PM - 2:15PM | GENERAL SESSION: COVID-19: An Evidence-Based Discussion on What We Have Learned
Kelly Fine, RPh, FAzPA;
Dawn Gerber, PharmD, BCGP, FASCP;
Andrew DeMotto, PharmD, BCPS, NCPS; Juan Villanueva, PharmD, BCPS, BCIDP


  • Review the current evidence-based treatments for COVID-19.
  • Evaluate the evidence behind the use of vitamins and over-the-counter products to prevent or treat COVID-19.
  • Identify impact of recent HHS authorizations for pharmacists.
  • Describe the pandemic vaccine plan for Arizona.

UAN: 0100-0000-20-150-L01-P/T

1:00PM - 2:00PM | BREAKOUT SESSION: Navajo Wellness : Diabetes & AADE 7™
Virginia M. Dayish, CNA, HT

Objectives: (Pharmacist Only)

  • Discuss the concepts of the Navajo Wellness Model and how they relate to the AADE7™ Self Care behaviors for diabetes education.
  • Illustrate the application of the Navajo Wellness Model with the AADE7™ Self Care Behaviors in diabetes education.
  • Recognize the value of integrating a Native/traditional wellness model in providing diabetes education.

UAN: 0100-9999-20-156-L01-P

2:15PM - 2:45PM | NON-ACCREDITED EDUCATION PROGRAM: Introduction to the FreeStyle Libre 2 CGM
Provided by Abbott

2:50PM - 3:50PM | BREAKOUT SESSION: Personal Burnout Strategies for the Pharmacy Professional
Michael Negrete, PharmD

Pharmacist/Technicians learning objectives:

  • Generate a sense of personal purpose and meaning.
  • Leverage a team workforce with its combination of personal strengths and abilities.
  • Stimulate drive for a persistent pursuit towards the achievement of mastery.
  • Enhance resilience through supporting personal health and wellbeing.
  • Discuss the importance of community in preventing/addressing burnout.

UAN: 0100-0000-20-126-L04-P/T

2:50PM - 3:50PM |BREAKOUT SESSION: Telepharmacy: A Patient's Perspective
Mitch Larson, BS

Pharmacists/Technicians learning objectives:

  • Analyze the current trends in the pharmacy industry and their effect on patient access.
  • Recognize the impact of telepharmcy on patients in rural and urban communities.
  • Describe the regulatory environment and what states are doing with rules surrounding telepharmacy.

UAN: 0100-0000-20-127-L04-P/T

2:50PM - 3:50PM | BREAKOUT SESSION: Not Just Lowering A1C: Improving Cardiovascular Outcomes in Adults
with Diabetes (REPEAT SESSION)
Nicole Early, PharmD, BCGP; Taylor Naberhaus, PharmD;
Elizabeth Pogge, PharmD, MPH, BCPS, FASCP

Objectives: (Pharmacist Only)

  • Identify cardiovascular outcomes from landmark trials involving antidiabetic agents, including SGLT2 inhibitors, GLP-1 receptor agonists, and dipeptidyl peptidase 4 inhibitors.
  • Compare risks and benefits of novel antidiabetic agents in adults.
  • Given a patient case, utilize current ADA guidelines and available clinical trial evidence to create a patient care plan for management of diabetes in patients who are at increased risk of cardiovascular disease.

UAN: 0100-9999-20-129-L01-P

3:50PM - 4:00PM | BREAK


Connect virtually with classmates, faculty, and preceptors



7:00AM - 7:55AM | GENERAL SESSION: Legislative Discussion and Town Hall
Jessie Armendt
Kelly Fine, RPh, FAzPA; Mark Boesen, PharmD, JD;
Ken Bykowski, RPh; Christi Jen, PharmD, BCPS, FAzPA; Christopher Edwards, PharmD, BCPS; Mindy Burnworth, PharmD, BCPS, FASHP, FAzPA

Pharmacists/Technicians learning objectives:

  • Evaluate critical legislative issues that will impact the practice of pharmacy.
  • Review legislation considered in Arizona that can impact the profession.

UAN: 0100-0000-20-146-L03-P/T

8:00AM - 9:00AM | GENERAL SESSION:  Gatekeepers in Prevention:  Az Community Pharmacy Perspective of Their Roles in the Drug Epidemic
Nina Vadiei, PharmD, BCPP; Beth Meyerson, MDiv, PhD.

Pharmacists/Technicians learning objectives:

  • Review the literature regarding the pharmacist’s role in the opioid epidemic.
  • Describe the types of innovative practices related to opioid pharm reduction that currently exist.
  • Recognize the perception of community pharmacists in Arizona on their role in reducing opioid addiction and overdose among their patients.
  • Identify intervention components which may be feasible to implement in community pharmacies to help increase addition screenings, brief interventions and referral to community services.

UAN: 0100-0000-20-128-L08-P/T

9:00AM - 9:30AM | NON-ACCREDITED EDUCATION PROGRAM: Update on U.S. Drug Importation
Provided by The Partnership for Safe Medicines

9:35AM - 10:35AM |BREAKOUT SESSION: Not Just Lowering A1C: Improving Cardiovascular Outcomes in Older Adults with Diabetes
Nicole Early, PharmD, BCPS, BCGP, FASCP; Elizabeth Pogge, PharmD, MPH, BCPS, FASCP; Taylor Naberhaus, PharmD

Pharmacist learning objectives:  (Pharmacist only)

  • Identify cardiovascular outcomes from landmark trials involving antidiabetic agents, including SGLT2 inhibitors,GLP-1 receptor agonists, and dipeptidyl peptidase 4 inhibitors.
  • Compare risks and benefits of novel antidiabetic agents in older adults.
  • Given a patient case, utilize current ADA guidelines and available clinical trial evidence to create a patient careplan for management of diabetes in patients who are at increased risk of cardiovascular disease.

UAN: 0100-0000-20-129-L01-P

9:35AM - 10:35AM | BREAKOUT SESSION: Pharmacy Technician Career Paths: Above and Beyond the Counter-Part 1
Jody McConkey, MPA/HCM, CPhT

Technician learning objectives:

  • Define traditional pharmacy technician roles and how expanded scope of practice impacts enhanced career opportunities.
  • Identify what other career paths exist beyond retail and hospital pharmacy due to the expanded scope of practice.
  • List next steps to achieve an enhanced pharmacy technician career path within the expanded scope of practice and other areas.

UAN: 0100-0000-20-130-L04-P/T

9:35AM - 10:35AM | BREAKOUT SESSION: The Preceptor-Mentor Sandwich and the “Meat” (Preceptee/Mentee) in the Middle
Mindy Burnworth, PharmD, BCPS, FASHP, FAzPA; Vanthida Huang, PharmD, FCCP

Pharmacist learning objectives:  (Pharmacist only)

  • Compare and contrast preceptorship and mentorship.
  • Develop a plan to grow into a quality preceptor and quality mentor.
  • Develop a plan to be the ideal preceptee and ideal mentee.

UAN: 0100-0000-20-131-L04-P

9:35AM - 10:35AM | BREAK

10:45AM - 11:45AM | BREAKOUT SESSION: That Doesn’t Sound Like Anything I Want To Do:  Precepting the Unmotivated or Unengaged Learner
Conchetta Lesser, PharmD, BCACP

Pharmacist learning objectives:  (Pharmacist only)

  • Identify signs of declining motivation or disengagement in APPE students and residents.
  • Give examples of behaviors indicating disengagement.
  • Design a plan to address lack of motivation.
  • Collaborate with student or resident for follow up on plan

UAN: 0100-0000-20-132-L04-P/T

10:45AM - 11:45AM |BREAKOUT SESSION: The Changing Landscape of Pharmacy Legislation & Regulations
Mark Boesen, PharmD, JD

Pharmacists/Technicians learning objectives:

  • Review the impact of various regulatory, legislative, and pandemic  changes on the opioid epidemic.
  • Discuss federal and state boards of pharmacy responses to COVID-19 across the country, with a specific focus on Arizona.
  • Describe other prevalent regulatory trends across the country as it pertains to pharmacist and technician scope of practice.

UAN: 0100-0000-20-133-L08-P/T

10:45AM - 11:45AM | BREAKOUT SESSION:  Pharmacy Technician Career Paths: Above and Beyond the Counter-Part 2
Kristen Snair, CPhT

Technician learning objectives: 

  • Identify what other career paths exist beyond retail and hospital pharmacy.
  • Recognize what skills can be developed now to get into those broader roles.
  • List next steps to achieve an enhanced pharmacy technician career path.

UAN: 0100-0000-20-134-L04-P/T

11:45AM - 12:15PM | BREAK


1:15PM - 1:30PM | BREAK

1:30PM - 3:00PM | BREAKOUT SESSION: New Drug Update 2020
Robert Lipsy, PharmD, BCACP, FASHP, FAzPA

Pharmacists/Technicians learning objectives:

  • Determine what new drugs and biologics offer the real possibility of a significant improvement in patient care.
  • Identify the appropriate place of bempedoic acid in the treatment of hypercholesterolemia.
  • List at least two new drugs for the treatment of migraine headaches.

UAN: 0100-0000-20-135-L01-P/T

1:30PM - 3:00PM | BREAKOUT SESSION: Hit Me With Your Best Shot: Advanced Immunizing for Complex Disease States
Holly Van Lew, PharmD, BCPS; Sophia Galloway, PharmD, BCACP

Pharmacist learning objectives:

  • Make appropriate vaccine recommendations based on recent updates to CDC immunization guidelines.
  • Evaluate the effects of immunosuppression on recommended vaccine schedules.
  • Develop individualized patient vaccination plans based on complex co-morbidities.
  • Identify specific immunization and titer requirements for healthcare personnel
  • Compare and contrast various approaches to addressing patients and family members with vaccine hesitancy.

UAN: 0100-0000-20-149-L06-P

3:05PM - 4:05PM | BREAKOUT SESSION:  Finding Reason:  Focus on Medication Errors and Patient Safety
Jeremy Gerber, PharmD, MBA, BCPS, BCOP

Pharmacists/Technicians learning objectives:

  • Compare/contrast the person-based versus the system-based approach to understanding error management.
  • Identify different tools and their reliability at preventig human medication errors.

UAN: 0100-0000-20-136-L05-P/T

3:05PM - 4:05PM | BREAKOUT SESSION:  Pragmatic Approaches to the Layered Learning Practice Model (LLPM)
Janet Cooley, PharmD; Suzanne Larson, PharmD; Jason Boanca, PharmD-Candidate 2021, MWU-G

Pharmacist learning objectives:

  • Define the Layered Learning Practice Model (LLPM).
  • Brainstorm ways to purposefully implement the 4 preceptor roles of instruction, modeling, coaching, and facilitating within the
  • Describe the benefits, limitations, and challenges of the LLPM.
  • Identify goals that would be mutually beneficial of the health system’s pharmacy department and the education of pharmacists in
    training across the IPPE/APPE/PGY1/PGY2 spectrum.

UAN: 0100-9999-20-138-L04-P

On-Demand Only Programs

Herbs, Vitamins and Medications in Breast Cancer
Dawn Gerber, PharmD, BCGP, FASCP; Jeremy Gerber, PharmD, MBA, BCPS, BCOP

Pharmacist learning objectives:

  • Describe how to apply genetic testing results to breast cancer medications.
  • List side effect management strategies for breast cancer treatments.
  • Identify the risks and benefits of specific vitamins and herbs during breast cancer treatment.

Technician learning objectives:

  • Identify how application of genetic testing results link to breast cancer medications.
  • List potential side effects to breast cancer treatments.
  • Describe the risks and benefits of specific vitamins and herbs during breast cancer treatment.   

UAN: 0100-0000-20-139-H01-P/T
Review of COPD Guidelines
Nick Ladziak, PharmD, BCACP

Pharmacist learning objectives:  (Pharmacist only)

  • Describe COPD and drug mechanisms of action in patient friendly terms.
  • Apply COPD treatment guidelines to a patient case
  • Counsel a patient on proper use of common medications
  • Recognize combination products used for the treatment of COPD.

UAN: 0100-0000-20-140-H01-P

I gave them feedback, why was there no change? Maximizing the Impact of Feedback You Give
Susana Horst, PharmD, BCACP

Pharmacist learning objectives:  (Pharmacist only)

  • Define different types of feedback.
  • Describe different methods to give feedback.
  • Differentiate between productive and non-productive language.
  • Identify opportunities to shift from one-way feedback to a two-way conversation.

UAN: 0100-0000-20-142-H04-P

Reviewing a Review:  Principles in the Evaluation of Systematic Reviews and Meta-Analyses
Stacy Haber, PharmD

Pharmacist learning objectives:  (Pharmacist only)

  • Identify the role of systematic reviews in the practice of evidence-based health care.
  • Identify the types of information displayed on a forest plot in a systematic review.
  • Interpret statistical tests that assess the level of heterogeneity in a meta-analysis.
  • Evaluate the appropriateness of various models to pool data in a meta-analysis.
  • Apply the findings of a meta-analysis to a patient case

UAN: 0100-0000-20-144-H04-P

From A-Z: Clinical Pearls for Pharmacy Professionals
Jacob Schwarz, PharmD, BCIDP, BCCCP, BCPS

Pharmacist learning objectives:  (Pharmacist only)

  • Evaluate clinical scenarios or “clinical pearls” that might not be widely known or published.
  • Apply novel clinical practice options for patient care in various health settings.
  • Describe medication management strategies in difficult or controversial patient care situations.
  • Assemble clinical information that can be applied to applicable work settings.

UAN: 0100-0000-20-145-H04-P/T

Registration Rates

Early Bird Member Prices

Premium Pharmacist: $175
Pharmacist: $195
Resident/Technician/Associate: $99
Student: $50

Early Bird Non-Member Prices 
Pharmacist: $245
Resident/Technician/Associate: $125
Student: $75

Note: Early Bird Rates for Pharmacists, Technicians and Residents will Increase by $25 after 9-14-20.